Latest News from NPR

on:

NCPR is supported by:

 
Hourly Newscast
4 min., 45 sec.

Programs

Latest program rundown

Coming up:

Latest Features:
September 2, 2014 | NPR · At a Labor Day picnic in Milwaukee, the president accused the GOP of blocking economic initiatives. He urged the sympathetic union audience to turn their frustration into political action in November.
 
AP
September 2, 2014 | NPR · The city's plan to restructure its debt has been praised as a creative way to protect both pensioners and its art museum. But some creditors — and residents — feel like they're being railroaded.
 
Courtesy of Prime Group
September 2, 2014 | NPR · A company called WTAS is reviving the defunct accounting firm's name and hoping clients have forgotten its associations with the Enron scandal.
 

Latest program rundown

Coming up:

Latest Features:
September 2, 2014 | NPR · The Islamist extremist group Islamic State has released a new video that purports to show the beheading of an American journalist named Steven Sotloff, whom the group threatened to kill two weeks ago.
 
September 2, 2014 | NPR · In response to unrest in eastern Ukraine, NATO is considering forming a rapid reaction force — a topic that will be discussed at a summit this week in Wales. But how will Russia react, and is this the right move for the alliance? To learn more, Audie Cornish speaks with Steven Pifer, the director of Arms Control and Non-Proliferation Initiative at the Brookings Institution.
 
NPR
September 2, 2014 | NPR · The Pentagon has been transferring mine-resistant, ambush-protected vehicles to local police. Built to protect U.S. forces from roadside bomb blasts at war, these huge vehicles aren't always welcome.
 

Latest Saturday rundown




WE Saturday Feature

August 30, 2014 | NPR · Ukrainian forces are defending the port city of Novoazovsk from what they say is a Russian invasion. Scott Simon talks to correspondent Soraya Sarhaddi Nelson.
 

Latest Sunday rundown


WE Sunday Feature

August 31, 2014 | NPR · Immigration remains one of the most challenging issues for President Obama. Political correspondent Mara Liasson discusses the political cost of the choices before him with Linda Wertheimer.
 

Latest program rundown

Coming up:

Pharmaceuticals

Aug 29, 2014 — Even when monkeys were near death, an Ebola treatment called ZMapp was able to save them. The drug has been used in a few people, but the limited supply has been exhausted.
Launch in player | Comments |
Aug 21, 2014 — Even though the current outbreak in West Africa has become the largest ever, Ebola isn't the most attractive business proposition for drugmakers. The right financial incentives might change that.
Comments |
Aug 8, 2014 — No doctor would refuse to prescribe cholesterol-lowering statins to patients because they're overweight. But despite guidelines, some doctors aren't offering preventive drugs to those at risk for HIV.
Launch in player | Comments |
Jul 25, 2014 — A husband and wife who are doctors have been working on fact boxes for drugs that, like nutrition labels for foods, would more concisely convey a medicine's benefits and risks.
Launch in player | Comments |
Jul 11, 2014 — There's overmedicating and self-medicating, but some vets are "de-medicating." Prescribed multiple drugs to deal with PTSD and pain, they've stopped taking them — without authorization.
Launch in player | Comments |
Jun 23, 2014 — Drugmakers offer medicines at a bargain price to hospitals that treat large numbers of poor patients. Hospitals sometimes resell the drugs at full price and make hefty profits.
Launch in player | Comments |
May 20, 2014 — Medicare gives itself the power to ban doctors if they prescribe medications in abusive ways. The action follows a ProPublica series that found inappropriate prescribing, waste and fraud.
Comments |
May 16, 2014 — The Food and Drug Administration's approval of a new drug for leishmaniasis came with a voucher that can be redeemed to speed up the approval of a much more lucrative drug in the future.
Comments |
May 12, 2014 — Once a drug is approved by the FDA, doctors can use it as they see fit. That can be brilliant or risky, depending on the medication and the patient.
Launch in player | Comments |
May 6, 2014 — German drug company Bayer makes a deal with U.S.-based Merck & Co. The purchase includes brands such as Claritin, Coppertone and Dr. Scholl's.
Comments |
more Pharmaceuticals from NPR